Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DNAlytics develops advanced data-driven solutions for the healthcare sector with deep expertise in biotechnology. Its flagship commercial product, RheumaKit, enables precise diagnosis of rheumatoid arthritis subtypes using RNA analysis from joint biopsies combined with clinical data. The company also provides AI-powered consulting services to accelerate drug discovery, biomarker identification, clinical trial optimization, and biomanufacturing process improvement. Over its history since spinning out of UCLouvain in Belgium in 2012, DNAlytics has completed more than 100 projects with private companies and academic partners. It continues to innovate through scientific publications and new diagnostic developments such as blood-based colon cancer tests.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DNAlytics.